Skip to Content

Symposia on Cancer Research 2013

Genomic Medicine

October 4-5, 2013

The University of Texas MD Anderson Cancer Center
R. Lee Clark Clinic
Floor 11
1515 Holcombe Boulevard
Houston, Texas

General Information

Call for Poster Abstract Deadline is August 1, 2013.

The mission of the University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

Educational Objectives

After attending the symposium, participants should be able to:

  • Describe and discuss the current best approaches to analyzing the cancer genome;
  • Explain one or two paradigms of how a genetic mutation in a cancer led to a new clinical approach;
  • Recognize how additional layers of biology beyond the genome, such as the metabolome or the proteome, are also venues for new drug discovery efforts;
  • Identify the latest advances in applying genomics to cancer diagnosis and therapy, and discuss the challenges in creating effective clinical interventions based on this new area of scientific investigation.

Goal

The goal of the symposium is to bring together world-renowned scientists to present and discuss novel basic, translational and clinical research being conducted in the area of genomic medicine as it relates to cancer. Topics will include:  broad based efforts to catalogue and understand genomic abnormalities in cancer and the role of comprehensive computational approaches in identifying the most meaningful of them; leveraging genomic science to go beyond into drug discovery and other omics; and the application of new found knowledge to the clinic to guide new clinical trials. Keynote speakers are Arul M. Chinnaiyan, MD, PhD (University of Michigan  School of Medicine)  and Gad Asher Getz, PhD (Broad Institute of MIT and Harvard). In addition, Mike Stratton, PhD (Wellcome Trust Sanger Institute) and Andrew Futreal, PhD (MD Anderson) will jointly receive the Ernst W. Bertner Memorial Award. Charles L. Sawyers, MD (Memorial Sloan-Kettering Cancer Center) will receive the Heath Memorial Award. There will also be a poster session for participants to represent their findings. The symposium begins Friday morning and will end Saturday afternoon.

Evaluation

A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status.   Participants will also have the
opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

Target Audience

The program will be of broad interest to scientists, scientists-in-training,  physicians, physicians-in-training, students, nurses, and fellows interested in hearing the newest advances in the area of genomic medicine.

Educational Methods

  • Lectures
  • Question-and-Answer Sessions
  • Panel Discussions
  • Posters

© 2013 The University of Texas MD Anderson Cancer Center